KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 1

The Relationship between Reproductive Hormone Levels and Osteoporosis

Semra EROGLU
Gulsah KARATAS
Sayfa
110–115
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

According to these findings, considering the higher risk of OP in patients with low E2 and highFSH levels, randomized-prospective studies should be conducted to determine whether prophylactic treatment shouldbe given to this group.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Changes in serum levels of follicle-stimulating hormone (FSH) and estradiol (E2) due to menopause arethe some of the most important factors for osteoporosis (OP).
📊
Temel Bulgular & Veri:The aim of this study was to evaluate the relationshipbetween bone mineral density (BMD) and reproductive hormone levels in postmenopausal women.Methods: A total of 144 postmenopausal women were divided into two groups according to their BMD, as obtainedusing dual-energy X-ray absorptiometry; 72 patients with low BMD and 72 healthy subjects.
💡
Sonuç & Katkı:According to these findings, considering the higher risk of OP in patients with low E2 and highFSH levels, randomized-prospective studies should be conducted to determine whether prophylactic treatment shouldbe given to this group.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: Changes in serum levels of follicle-stimulating hormone (FSH) and estradiol (E2) due to menopause arethe some of the most important factors for osteoporosis (OP). The aim of this study was to evaluate the relationshipbetween bone mineral density (BMD) and reproductive hormone levels in postmenopausal women.Methods: A total of 144 postmenopausal women were divided into two groups according to their BMD, as obtainedusing dual-energy X-ray absorptiometry; 72 patients with low BMD and 72 healthy subjects. Fasting blood sampleswere obtained from all participants for serum hormone levels, which were compared between the two groups.Results: The FSH levels were significantly higher in the low BMD group (49.76±27.61 IU/L vs. 57.30±24.83 IU/L,p=0.001), and serum E2 levels were statistically lower in the low BMD group (39.25±22.11 pg/mL vs. 30.12±18.16 pg/mL, p=0.046). The time elapsed after the onset of menopause was longer in the low BMD group (p=0.002).Conclusion: The low E2 and high FSH levels after the onset of menopause were associated with low BMD in postmenopausal women. According to these findings, considering the higher risk of OP in patients with low E2 and highFSH levels, randomized-prospective studies should be conducted to determine whether prophylactic treatment shouldbe given to this group.

🔖

Bu Makaleye Atıf Yap

EROGLU, S., KARATAS, G. (2022). The Relationship between Reproductive Hormone Levels and Osteoporosis. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 1, 110–115. https://ajindex.com/articles/508623

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Victorino VJ, Panis C, Campos FC, Cayres RC, Colado-Simão AN, Oliveira SR, Cecchini R. Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women. Age 2013;35:1411–21
  2. Indumati V, Patil VS, Jailkhani R. Hospital-based preliminary study on osteoporosis in postmenopausal women. Indian J Clin Biochem 2007;22:96–100
  3. Lindsay R. Hormones and bone health in postmenopausal women. Endocrine 2004;24:223–71 4. Yun BH, Chon SJ, Choi YS, Cho S, Lee BS, Seo SK. The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level. Osteoporosis International 2016;27:2745–53
  4. Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol 2017;4:46–56
  5. Society NAM. NAMS Continuing medical education activity; Management of osteoporosis in postmenopausal women: 2010 position statement. Menopause 2010;17:23–56
  6. Van Geel TA, Geusens PP, Winkens B, Sels JP, Dinant GJ. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol 2009;160:681–7
  7. Pardhe BD, Pathak S, Bhetwal A, Ghimire S, Shakya S, Khanal PR, Marahatta SB. Effect of age and estrogen on biochemical markers of bone turnover in postmenopausal women: a population-based study from Nepal. International journal of women's health 2017;9:781
  8. Sowers MR, Jannausch M, McConnell D, Little R, Greendale GA, Finkelstein JS, Ettinger B. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006;91:1261–7
  9. Bainbridge KE, Sowers MF, Crutchfield M, Lin X, Jannausch M, Harlow SD. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 2002;156:410–417
  10. Miller AJ, Jones C, Liss F, Abboudi J, Kirkpatrick W, Beredjiklian P. Qualitative evaluation of digital hand x-rays is not a reliable method to assess bone mineral density. Arch Bone Jt Surg 2017;5:10–13
  11. Jiang X, Good LE, Spinka R, Schnatz PF. Osteoporosis screening in postmenopausal women aged 50–64 years: BMI alone compared with current screening tools. Maturitas 2006;83:59– 64
  12. Sharami SH, Millani F, Alizadeh A, Ranjbar ZA, Shakiba M. risk factors of osteoporosis in over 50-year-old women, a population–based study in the north of Iran. J Turk G